457 related articles for article (PubMed ID: 28445690)
21. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression.
Brunoni AR; Padberg F; Vieira ELM; Teixeira AL; Carvalho AF; Lotufo PA; Gattaz WF; Benseñor IM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():211-217. PubMed ID: 29894705
[TBL] [Abstract][Full Text] [Related]
22. Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder.
Gao W; Gao Y; Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
BMC Psychiatry; 2024 Jun; 24(1):449. PubMed ID: 38877455
[TBL] [Abstract][Full Text] [Related]
23. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
[TBL] [Abstract][Full Text] [Related]
24. Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression.
Ormstad H; Dahl J; Verkerk R; Andreassen OA; Maes M
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1286-96. PubMed ID: 27237997
[TBL] [Abstract][Full Text] [Related]
25. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach.
Inamdar A; Merlo-Pich E; Gee M; Makumi C; Mistry P; Robertson J; Steinberg E; Zamuner S; Learned S; Alexander R; Ratti E
J Psychopharmacol; 2014 Jun; 28(6):570-81. PubMed ID: 24699061
[TBL] [Abstract][Full Text] [Related]
27. Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial.
Brunoni AR; Machado-Vieira R; Zarate CA; Valiengo L; Vieira EL; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
Psychopharmacology (Berl); 2014 Apr; 231(7):1315-23. PubMed ID: 24150249
[TBL] [Abstract][Full Text] [Related]
28. Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.
Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
Int Immunopharmacol; 2023 May; 118():110108. PubMed ID: 37004349
[TBL] [Abstract][Full Text] [Related]
29. Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.
Lee H; Song M; Lee J; Kim JB; Lee MS
J Affect Disord; 2020 Apr; 266():57-62. PubMed ID: 32056928
[TBL] [Abstract][Full Text] [Related]
30. Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
Haroon E; Daguanno AW; Woolwine BJ; Goldsmith DR; Baer WM; Wommack EC; Felger JC; Miller AH
Psychoneuroendocrinology; 2018 Sep; 95():43-49. PubMed ID: 29800779
[TBL] [Abstract][Full Text] [Related]
31. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy.
Sutcigil L; Oktenli C; Musabak U; Bozkurt A; Cansever A; Uzun O; Sanisoglu SY; Yesilova Z; Ozmenler N; Ozsahin A; Sengul A
Clin Dev Immunol; 2007; 2007():76396. PubMed ID: 18317531
[TBL] [Abstract][Full Text] [Related]
32. Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder.
Hernández ME; Mendieta D; Martínez-Fong D; Loría F; Moreno J; Estrada I; Bojalil R; Pavón L
Eur Neuropsychopharmacol; 2008 Dec; 18(12):917-24. PubMed ID: 18805677
[TBL] [Abstract][Full Text] [Related]
33. Cytokines: abnormalities in major depression and implications for pharmacological treatment.
O'Brien SM; Scott LV; Dinan TG
Hum Psychopharmacol; 2004 Aug; 19(6):397-403. PubMed ID: 15303243
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory Profiles in Depressed Adolescents Treated with Fluoxetine: An 8-Week Follow-up Open Study.
Pérez-Sánchez G; Becerril-Villanueva E; Arreola R; Martínez-Levy G; Hernández-Gutiérrez ME; Velasco-Velásquez MA; Alvarez-Herrera S; Cruz-Fuentes C; Palacios L; de la Peña F; Pavón L
Mediators Inflamm; 2018; 2018():4074051. PubMed ID: 30662368
[TBL] [Abstract][Full Text] [Related]
35. Total and ionized calcium and magnesium are significantly lowered in drug-naïve depressed patients: effects of antidepressants and associations with immune activation.
Al-Dujaili AH; Al-Hakeim HK; Twayej AJ; Maes M
Metab Brain Dis; 2019 Oct; 34(5):1493-1503. PubMed ID: 31292851
[TBL] [Abstract][Full Text] [Related]
36. Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial.
Gadad BS; Jha MK; Grannemann BD; Mayes TL; Trivedi MH
J Psychiatr Res; 2017 Nov; 94():1-6. PubMed ID: 28628884
[TBL] [Abstract][Full Text] [Related]
37. Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda.
Musinguzi K; Obuku A; Nakasujja N; Birabwa H; Nakku J; Levin J; Kinyanda E
BMC Immunol; 2018 Jan; 19(1):1. PubMed ID: 29298663
[TBL] [Abstract][Full Text] [Related]
38. Cytokine serum levels remain unchanged during lithium augmentation of antidepressants in major depression.
Ricken R; Busche M; Schlattmann P; Himmerich H; Bopp S; Bschor T; Richter C; Stamm TJ; Heinz A; Hellweg R; Lang UE; Adli M
J Psychiatr Res; 2018 Jan; 96():203-208. PubMed ID: 29101798
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory biomarkers as differential predictors of antidepressant response.
Hashimoto K
Int J Mol Sci; 2015 Apr; 16(4):7796-801. PubMed ID: 25856677
[TBL] [Abstract][Full Text] [Related]
40. Indoleamine 2,3-dioxygenase and immune changes under antidepressive treatment in major depression in females.
Zoga M; Oulis P; Chatzipanagiotou S; Masdrakis VG; Pliatsika P; Boufidou F; Foteli S; Soldatos CR; Nikolaou C; Papageorgiou C
In Vivo; 2014; 28(4):633-8. PubMed ID: 24982234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
